Dinoprostone is a naturally occurring prostaglandin E2 (PGE2). It has important effects in labour. It also stimulates osteoblasts to release factors which stimualtes bone resorption by osteoclasts. As a prescription drug it is used as a vaginal suppository, to prepare the cervix for labour and to induce labour.
For the termination of pregnancy during the second trimester (from the 12th through the 20th gestational week as calculated from the first day of the last normal menstrual period), as well as for evacuation of the uterine contents in the management of missed abortion or intrauterine fetal death up to 28 weeks of gestational age as calculated from the first d...
Rambam health care campus, Haifa, Israel
Centre Hospitalier Vendée, La Roche sur Yon, France
Centre Hospitalier, Le Mans, France
Department of Obstetrics and Gynecology Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
Department of Obstetrics and Gynecology Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
Ain Shams Maternity hospital, Cairo, Egypt
Regina Qu'Appelle Health Region, Regina, Saskatchewan, Canada
BicĂȘtre Hospital, Le Kremlin-BicĂȘtre, France
Hospital Poissy, Poissy, France
HĂŽpitaux Universitaires de Strasbourg, Strasbourg, France
UniversitÀtsfrauenklinik Innsbruck, Medizinische UniversitÀt Innsbruck, Innsbruck, Austria
UniversitĂ€tsklinik fĂŒr Frauenheilkunde und Geburtshilfe, Medizinische UniversitĂ€t Graz, Graz, Austria
UniversitĂ€tsfrauenklinik Wien, Abteilung fĂŒr Geburtshilfe und fetomaternale Medizin, Medizinische UniversitĂ€t Wien, Vienna, Austria
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.